Keymed Biosciences Inc. held its Annual General Meeting on June 26, 2025. During the meeting, several proposals were presented and approved. These included the re-election of Dr. Bo Chen, Dr. Changyu Wang, and Dr. Gang Xu as executive directors, and the re-election of Mr. Qi Chen, Dr. Min Chuan Wang, and Mr. Yilun Liu as non-executive directors. Additionally, Prof. Xiao-Fan Wang, Prof. Yang Ke, and Mr. Cheuk Kin Stephen Law were re-elected as independent non-executive directors. All proposals were passed by shareholders as ordinary resolutions.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。